Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Endocrine Cancers

4 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCMD15107

    11/07/2017

    A Phase 1/2a Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of PLX8394 in Patients with Advanced, Unresectable Solid Tumors

    Treatment

    VICCTHO1722

    05/26/2017

    Phase I Study of TRC102 in Combination with Cisplatin and Pemetrexed in Patients with Advanced Solid Tumors, with Expansion Cohort in Mesothelioma / Phase II Study of TRC102 with Pemetrexed in Patients Refractory to Pemetrexed and Cisplatin or Carboplatin

    Treatment

    VICCPED16157

    04/24/2017

    NMTT-Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)

    Treatment

    VICCMD15110

    04/05/2016

    A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors


    Print this page for your doctor